Isoindole Dione Synthesis E-Isomer Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis routes for 2-[(2E)-2-fluoro-2-(3-piperidinylidene)ethyl]-1H-isoindole-1,3(2H)-dione and its hydrochloric acid salt suffer from lack of selectivity, producing significant amounts of the undesired Z-isomer, which requires additional time-consuming separation steps.
Innovation Solution
A process involving the reaction of specific compounds in a reaction-inert solvent, followed by reduction and subsequent Mitsunobu reaction conditions to achieve a higher ratio of the desired E-isomer, with optional deprotection methods to obtain the final compound or its salt, utilizing known reducing agents and solvents like toluene and diisopropyl ether.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the Wadsworth-Emmons-Homer reaction is used to prepare compound (1) as disclosed in WO-2008/005670, then the synthesis can be completed with a straightforward reaction protocol, but the reaction lacks selectivity and produces the undesired Z-isomer in large quantities requiring additional separation steps
Solution Approach 1:
The patent changes the reaction parameters by using a different base (sodium hydride instead of the traditional Wadsworth-Emmons-Homer bases) and conducting the reaction in a specific solvent system (ethyl methyl carbonate) at controlled temperatures. These parameter changes result in high E-isomer selectivity (E:Z ratio of 97:3 or better) while maintaining a straightforward reaction protocol, thus resolving the contradiction between ease of manufacture and manufacturing precision.
2Manufacturing precision
If additional separation steps are implemented to remove the Z-isomer, then the E-isomer purity is improved, but the synthesis time and process complexity increase
Solution Approach 1:
The patent applies preliminary action by optimizing the reaction conditions beforehand to produce the E-isomer with high selectivity (97:3 E:Z ratio) directly in the reaction mixture. This preliminary optimization of reaction parameters prevents the formation of large quantities of Z-isomer, thereby eliminating the need for subsequent time-consuming separation steps and resolving the contradiction between E-isomer purity and separation process time.
3Quantity of substance
If the reaction produces the Z-isomer in large quantities, then the overall material yield may be maintained, but the waste production increases and requires additional separation steps
Solution Approach 1:
The patent changes the reaction parameters by using sodium hydride as the base in ethyl methyl carbonate solvent, which selectively promotes E-isomer formation. This results in high E-isomer selectivity (97:3 ratio) and reduces Z-isomer waste production, thereby resolving the contradiction between overall yield and waste material by maintaining high yield of the desired E-isomer while minimizing unwanted byproducts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method improves the E:Z ratio and overall yield, reducing waste and simplifying the synthesis by minimizing the need for additional separation steps, thereby enhancing the efficiency of the process.
Implementation Method 1
reacting a compound of formula (I) with a compound of formula (II) to thereby forming a compound of formula (III)
Implementation Method 2
compound (E)-(III) is then converted in to compound (1) or its hydrochloric acid addition salt thereof
Implementation Method 3
followed by isolating compound (E)-(IV) or a salt thereof as a precipitate
Data Source
AI summary
The present invention relates to an improved process for preparing 2-[(2E)-2-fluoro-2-(3-piperidinylidene)ethyl]-1H-isoindole-1,3(2H)-dione, or a salt thereof, which is an intermediate in the synthesis route of the antibacterial compound 7-[(3E)-3-(2-amino-1- fluoroethylidene)-1-piperidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo 3-quinolinecarboxylic acid.